Vacc-4x clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses Vacc-4x is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Vacc-4x
- 4
Studies by the year they started
4 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Bionor Immuno AS (3) · Oslo University Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Vacc-4x is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Re-boosting of HIV-1 Infected Subjects With Vacc-4xCompletedPhase 2Bionor Immuno ASNCT01712256Written as Vacc-4x
- Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 ReservoirCompletedPhase 1/2Bionor Immuno ASNCT02092116Written as Vacc-4x
- Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIVCompletedPhase 2Bionor Immuno ASNCT00659789Written as Vacc-4x
- Intranasal Modified Vacc-4x Gag Peptides With Endocine as AdjuvantCompletedPhase 1/2Oslo University HospitalNCT01473810Written as Vacc-4x low dose